Skip to main content

1 Result(s)

within Moussa Seydi Remove this filter Biomedicine Remove this filter

and

  1. Article

    Open Access

    In vitro activity of dolutegravir against wild-type and integrase inhibitor-resistant HIV-2

    Dolutegravir recently became the third integrase strand transfer inhibitor (INSTI) approved for use in HIV-1–infected individuals. In contrast to the extensive dataset for HIV-1, in vitro studies and clinical ...

    Robert A Smith, Dana N Raugi, Charlotte Pan, Papa Salif Sow, Moussa Seydi… in Retrovirology (2015)

    Download PDF (979 KB) View Article